Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LVTX |
---|---|---|
09:43 ET | 2205 | 2.3801 |
09:52 ET | 3333 | 2.3301 |
09:56 ET | 7360 | 2.34 |
10:14 ET | 100 | 2.33 |
10:15 ET | 200 | 2.32 |
10:21 ET | 100 | 2.3168 |
10:24 ET | 3960 | 2.31 |
10:32 ET | 424 | 2.323 |
10:35 ET | 800 | 2.32 |
10:53 ET | 300 | 2.33 |
11:22 ET | 1018 | 2.32 |
11:26 ET | 4200 | 2.31 |
11:29 ET | 200 | 2.31 |
11:47 ET | 100 | 2.33 |
12:32 ET | 500 | 2.3 |
12:50 ET | 150 | 2.315 |
01:01 ET | 638 | 2.315 |
01:14 ET | 2000 | 2.3001 |
01:17 ET | 100 | 2.32 |
01:57 ET | 3350 | 2.32 |
02:26 ET | 200 | 2.33 |
02:44 ET | 100 | 2.32 |
02:56 ET | 100 | 2.32 |
03:14 ET | 5000 | 2.3101 |
03:16 ET | 100 | 2.32 |
03:20 ET | 5000 | 2.32 |
03:34 ET | 150 | 2.3232 |
03:59 ET | 343 | 2.34 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
LAVA Therapeutics NV | 61.5M | -2.2x | --- |
Kronos Bio Inc | 64.9M | -0.5x | --- |
Atara Biotherapeutics Inc | 61.5M | -0.2x | --- |
Cue Biopharma Inc | 66.2M | -1.3x | --- |
Kezar Life Sciences Inc | 49.7M | -0.5x | --- |
BioLine RX Ltd | 55.9M | -0.9x | --- |
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $61.5M |
---|---|
Revenue (TTM) | $12.5M |
Shares Outstanding | 26.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.07 |
Book Value | $1.95 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 4.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -252.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.